Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

CRMP-2 Inhibitors

CRMP-2 inhibitors constitute a class of chemical compounds specifically designed to target and modulate the activity of the collapsin response mediator protein 2 (CRMP-2). Also known as dihydropyrimidinase-related protein 2 (DPYSL2), CRMP-2 is a cytosolic phosphoprotein with critical functions in various cellular processes, particularly in neuronal development, axonal guidance, and regulation of microtubule dynamics. The chemical structures of CRMP-2 inhibitors can vary widely, and their design often involves careful consideration of the key functional groups required to interact with the active site of CRMP-2. Some inhibitors may be natural products from plants or microorganisms, while others are synthetically designed molecules tailored to bind specifically to CRMP-2. Researchers employ a diverse array of methodologies to identify and develop CRMP-2 inhibitors, including computational techniques, high-throughput screening, and rational drug design.

Mechanistically, CRMP-2 inhibitors aim to interfere with the phosphorylation or cleavage of CRMP-2, which are essential post-translational modifications involved in its activity. By targeting these regulatory processes, the inhibitors may alter CRMP-2's interactions with other cellular proteins and its involvement in neuronal signaling pathways. Furthermore, some CRMP-2 inhibitors may act indirectly by affecting downstream signaling pathways or interacting with other molecular partners that interact with CRMP-2. As part of the ongoing research, studies utilize in vitro and cellular assays to assess the potency, selectivity, and mode of action of CRMP-2 inhibitors. Moreover, structural biology techniques, such as X-ray crystallography or NMR spectroscopy, are employed to elucidate the three-dimensional interactions between CRMP-2 and its inhibitors. By deciphering the precise roles and interactions of CRMP-2 in different cellular contexts, researchers hope to gain valuable insights into the complex processes that govern neuronal growth, plasticity, and connectivity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium, commonly used as a mood stabilizer in bipolar disorder, has been shown to inhibit CRMP-2 phosphorylation, which is essential for its function in axonal guidance.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine has been shown to reduce CRMP-2 phosphorylation by inhibiting Cdk5 activity.

Fasudil, Monohydrochloride Salt

105628-07-7sc-203418
sc-203418A
sc-203418B
sc-203418C
sc-203418D
sc-203418E
sc-203418F
10 mg
50 mg
250 mg
1 g
2 g
5 g
10 g
$18.00
$33.00
$87.00
$168.00
$253.00
$496.00
$910.00
5
(1)

Fasudil is a Rho kinase (ROCK) inhibitor that has been studied for its potential CRMP-2 modulation.

(−)-Huperzine A

102518-79-6sc-200183
sc-200183A
1 mg
5 mg
$143.00
$362.00
1
(1)

Huperzine A is a natural acetylcholinesterase inhibitor and has been investigated for its neuroprotective effects, which may involve CRMP-2 regulation.

K-252a

99533-80-9sc-200517
sc-200517B
sc-200517A
100 µg
500 µg
1 mg
$129.00
$214.00
$498.00
19
(2)

K252a is a natural product that has been found to inhibit CRMP-2 phosphorylation by inhibiting the activity of various kinases.

Erbstatin Analog

63177-57-1sc-200511
sc-200511A
5 mg
25 mg
$83.00
$305.00
4
(1)

This compound has been identified as a CRMP-2 inhibitor and might have potential neuroprotective effects.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Leptomycin B is a natural product that has been found to inhibit CRMP-2 nuclear export, affecting its function in the nucleus.

Isobavachalcone

20784-50-3sc-202666
1 mg
$213.00
1
(1)

Isobavachalcone is a flavonoid compound with reported CRMP-2 inhibitory activity, and it has been investigated for its potential neuroprotective effects.